Holen Sie sich die Stockscreener-App
110.53
0.41%
-0.46
Vorhandelsmarkt:
110.73
0.20
+0.18%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$110.99
Offen:
$110.87
24-Stunden-Volumen:
10.88M
Relative Volume:
0.82
Marktkapitalisierung:
$274.34B
Einnahmen:
$63.90B
Nettoeinkommen (Verlust:
$19.05B
KGV:
14.62
EPS:
7.5596
Netto-Cashflow:
$13.05B
1W Leistung:
+3.83%
1M Leistung:
+14.08%
6M Leistung:
+32.04%
1J Leistung:
+10.70%
1-Tages-Spanne:
$110.22
$112.48
1-Wochen-Bereich:
$105.80
$112.90
52-Wochen-Spanne:
$73.31
$112.90
Merck Co Inc Stock (MRK) Company Profile
Firmenname
Merck Co Inc
Sektor
Telefon
908-740-4000
Adresse
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Vergleichen Sie MRK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
110.53 | 275.48B | 63.90B | 19.05B | 13.05B | 7.5596 |
|
LLY
Lilly Eli Co
|
1,063.56 | 971.27B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
204.39 | 495.71B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
220.08 | 396.12B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
141.54 | 271.43B | 54.45B | 14.42B | 17.15B | 7.333 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-08 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-10-13 | Fortgesetzt | Citigroup | Neutral |
| 2025-09-17 | Herabstufung | Berenberg | Buy → Hold |
| 2025-05-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-22 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-08 | Herabstufung | Truist | Buy → Hold |
| 2024-12-20 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-04 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-11 | Herabstufung | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-03-11 | Herabstufung | Societe Generale | Hold → Sell |
| 2024-01-04 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-27 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-14 | Eingeleitet | HSBC Securities | Hold |
| 2023-04-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-03-28 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-03-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Eingeleitet | Jefferies | Buy |
| 2023-02-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
| 2022-10-10 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-09-14 | Hochstufung | Berenberg | Hold → Buy |
| 2022-07-06 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Fortgesetzt | SVB Leerink | Outperform |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Eingeleitet | Goldman | Buy |
| 2021-12-16 | Eingeleitet | Daiwa Securities | Neutral |
| 2021-12-13 | Herabstufung | UBS | Buy → Neutral |
| 2021-12-09 | Eingeleitet | Wells Fargo | Overweight |
| 2021-12-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-11-29 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-11-01 | Hochstufung | Argus | Hold → Buy |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Fortgesetzt | Truist | Buy |
| 2021-05-20 | Herabstufung | Argus | Buy → Hold |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Fortgesetzt | Bernstein | Outperform |
| 2020-09-29 | Eingeleitet | Berenberg | Hold |
| 2020-08-03 | Hochstufung | Goldman | Neutral → Buy |
| 2020-06-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-01-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-16 | Eingeleitet | SVB Leerink | Outperform |
| 2019-07-03 | Eingeleitet | Mizuho | Buy |
| 2019-05-28 | Eingeleitet | Goldman | Neutral |
| 2019-05-13 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Bestätigt | Citigroup | Buy |
| 2018-10-09 | Fortgesetzt | Guggenheim | Buy |
| 2018-04-23 | Hochstufung | Goldman | Neutral → Buy |
| 2018-04-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-02-07 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Hochstufung | SunTrust | Hold → Buy |
Alle ansehen
Merck Co Inc Aktie (MRK) Neueste Nachrichten
Merck & Co., Inc. $MRK Shares Bought by Godsey & Gibb Inc. - MarketBeat
Merck (MRK) stock week ahead: $30 billion Revolution talks and JPMorgan catalysts to watch - TechStock²
New York State Teachers Retirement System Lowers Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Key deals this week: Merck, Glencore, CrowdStrike, Marvell Technology, Steel Dynamics and more - Seeking Alpha
Merck & Co., Inc. $MRK Shares Purchased by Sumitomo Mitsui DS Asset Management Company Ltd - MarketBeat
Narwhal Capital Management Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat
Eikon Therapeutics Files for IPO Led By Merck Veterans - Bloomberg.com
Merck in Talks to Buy Revolution Medicines Per Financial Times Report - Finviz
Merck (MRK) stock today: $32 billion Revolution talks and CDC vaccine shift put Feb. 3 in play - TechStock²
Merck & Co., Inc. $MRK Stock Position Cut by State of Alaska Department of Revenue - MarketBeat
Nisa Investment Advisors LLC Sells 125,886 Shares of Merck & Co., Inc. $MRK - MarketBeat
Next Level Private LLC Lowers Position in Merck & Co., Inc. $MRK - MarketBeat
The Dogs of the Dow: 10 Downtrodden Dividends Paying Out Up to 6.8% - Investing.com
Park Avenue Securities LLC Acquires 18,839 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck in Talks to Buy Biotech Revolution Medicines, FT Says - Bloomberg.com
Merck reportedly consiering a major acquisition (Revolution Medicines) - marketscreener.com
Merck & Co., Inc. $MRK Shares Acquired by Capital Investment Advisors LLC - MarketBeat
Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight - Benzinga
Where is Merck & Co. (MRK) headed according to Wall Street? - MSN
Wells Fargo Adds Merck (MRK) to Q1 2026 Tactical List Ahead of Key Catalysts - Finviz
Merck urges science-led US vaccine schedule after CDC trims childhood vaccine list - Reuters
Merck & Co., Inc. (NYSE:MRK) Shares Up 2.1% Following Analyst Upgrade - MarketBeat
Merck might buy Revolution Medicines - breakingthenews.net
Merck upgraded, AbbVie downgraded at Wolfe (MRK:NYSE) - Seeking Alpha
Why Merck (MRK) is a Top Growth Stock for the Long-Term - Yahoo Finance Singapore
Merck & Co., Inc. (NYSE:MRK) Stock Rating Upgraded by Wolfe Research - MarketBeat
United Asset Strategies Inc. Acquires 21,765 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck: Fundamentals Amplified By A Momentum Breakout (NYSE:MRK) - Seeking Alpha
Merck & Co., Inc. $MRK Shares Bought by HB Wealth Management LLC - MarketBeat
214,812 Shares in Merck & Co., Inc. $MRK Purchased by Moran Wealth Management LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by CX Institutional - MarketBeat
Merck & Co (MRK) Sees Analyst Rating Boost with Raised Price Tar - GuruFocus
Merck & Co., Inc. (NYSE:MRK) Given New $130.00 Price Target at UBS Group - MarketBeat
Citigroup Increases Merck & Co., Inc. (NYSE:MRK) Price Target to $110.00 - MarketBeat
Breaking Down Merck & Co: 10 Analysts Share Their Views - Benzinga
Retail Trends: Is Merck Co Inc stock a safe haven assetNew Guidance & Safe Entry Momentum Stock Tips - moha.gov.vn
Merck to Complete Acquisition of Cidara Therapeutics - BioSpace
Merck to Hold Fourth-Quarter and Full-Year 2025 Sales and Earnings Conference Call Feb. 3 - pharmiweb.com
KLP Kapitalforvaltning AS Raises Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Securian Asset Management Inc. - MarketBeat
Cerity Partners LLC Sells 277,099 Shares of Merck & Co., Inc. $MRK - MarketBeat
308,800 Shares in Merck & Co., Inc. $MRK Bought by Adams Diversified Equity Fund Inc. - MarketBeat
WALB Investigates: Merck moves to dismiss Flint River Plant cancer lawsuit - WALB
US Cuts Childhood Vaccine Schedule To 11 Core Shots— What It Means For Vaccine Makers Like Merck And GSK - Benzinga
Merck & Co., Inc. $MRK Shares Sold by Spirepoint Private Client LLC - MarketBeat
Robeco Institutional Asset Management B.V. Sells 157,285 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co.'s Q4 2025 Earnings: What to Expect - Barchart.com
Merck & Co’s Stock Walks a Tightrope Between Defensive Strength and Lofty Expectations - AD HOC NEWS
Almanack Investment Partners LLC. Reduces Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Hits New 52-Week HighWhat's Next? - MarketBeat
44th Annual J.P. Morgan Healthcare Conference - Merck.com
Finanzdaten der Merck Co Inc-Aktie (MRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.06%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):